Preauthorization Exemptions (Implementation of HB 3459)
Governs Texas Department of Insurance rules implementing HB 3459 about when issuers may grant, deny, or rescind preauthorization exemptions for physicians and providers making preauthorization requests; affects issuers, physicians, providers, and utilization review agents operating in Texas.
New Division 2 (§§19.1730 - 19.1733) establishing preauthorization exemption rules was adopted to implement HB 3459.
Minimum threshold for eligible preauthorization requests for evaluation reduced from 20 to five.
Definition changes clarify that 'eligible preauthorization request' and 'evaluation' refer to retrospective review of a random sample and count approved or adverse determinations per eligible request.
Issuers must give notice within five days of completing an evaluation and include plain-language explanation and coding guidance in exemption notices.
The term 'full and final approval' was replaced with 'eligible' in the definition of 'denial of preauthorization exemption' and 'evaluation' language was updated to reference 'eligible preauthorization requests.'
The definition of 'evaluation' was clarified to require retrospective review of a random sample for rescission determinations and tied to Insurance Code §4201.655.
Subsection added requiring claims to include ordering physician/provider name and NPI in claim fields (CMS 1500 Box 17/17B, UB-04 fields 76-79 or corresponding electronic fields) so exemptions can be applied.
Minimum threshold to qualify for an initial preauthorization exemption was reduced from 20 requests to five eligible preauthorization requests during the evaluation period.
TDI clarified that 'particular health care service' can include pharmaceutical services and prescription drugs under Insurance Code definitions and declined to narrowly limit the term.
Definition of 'treating physician or provider' broadened to 'health and medical care' and explicitly includes an 'ordering' physician or provider.
TDI confirmed rescission determinations must be based on a random sample and incorporated statutory requirements by reference rather than restating them in full.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.